Bank Of New York Mellon Corp Provention Bio, Inc. Transaction History

Bank Of New York Mellon Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $1.2 Million - $2.8 Million	265,132 New	265,132 $2.8 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $142,934 - $234,196	41,672 Added 24.18%	214,030 $963,000
Q2 2022 Aug 15, 2022	SELL	$3.65 - $7.3 $118,825 - $237,651	-32,555 Reduced 15.89%	172,358 $690,000
Q1 2022 May 11, 2022	SELL	$3.4 - $7.88 $36,890 - $85,498	-10,850 Reduced 5.03%	204,913 $1.5 Million
Q4 2021 Feb 11, 2022	SELL	$5.59 - $7.39 $71,585 - $94,636	-12,806 Reduced 5.6%	215,763 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$5.66 - $8.33 $174,158 - $256,314	30,770 Added 15.56%	228,569 $1.46 Million
Q2 2021 Aug 11, 2021	BUY	$6.71 - $11.04 $119,236 - $196,180	17,770 Added 9.87%	197,799 $1.67 Million
Q1 2021 May 13, 2021	BUY	$10.12 - $19.45 $34,306 - $65,935	3,390 Added 1.92%	180,029 $1.89 Million
Q4 2020 Feb 09, 2021	BUY	$11.79 - $18.94 $60,400 - $97,029	5,123 Added 2.99%	176,639 $2.99 Million
Q3 2020 Nov 12, 2020	BUY	$10.34 - $15.2 $106,956 - $157,228	10,344 Added 6.42%	171,516 $2.2 Million
Q2 2020 Aug 12, 2020	BUY	$7.81 - $17.0 $1.08 Million - $2.36 Million	138,666 Added 616.13%	161,172 $2.27 Million
Q1 2020 May 06, 2020	SELL	$5.42 - $17.75 $135,500 - $443,750	-25,000 Reduced 52.62%	22,506 $207,000
Q4 2019 Feb 14, 2020	BUY	$5.84 - $14.9 $206,899 - $527,877	35,428 Added 293.33%	47,506 $707,000
Q3 2019 Nov 07, 2019	BUY	$6.83 - $13.0 $82,492 - $157,014	12,078 New	12,078 $82,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.